# Plain Language Summary of H.R. 2330

This bill puts a cap on how much money can be spent on the Western Hemisphere Drug Policy Commission's operating costs for 2024. Specifically, it limits spending on salaries and expenses to no more than $1.5 million for that fiscal year. The Western Hemisphere Drug Policy Commission is a government organization that works on drug-related issues and policy across the Americas, and this bill is essentially saying "you can't spend more than this amount on running the organization and paying your staff."

For most everyday Americans, this bill won't have a direct impact on their daily lives. However, it could affect the commission's ability to carry out its work on international drug policy coordination with countries in North and South America. If the commission was previously spending more than $1.5 million on operations, they would need to reduce their budget—potentially cutting staff, scaling back programs, or limiting their activities. This could slow down or reduce their efforts to coordinate drug enforcement and policy initiatives across the Western Hemisphere, though the practical effects would depend on what the commission was actually doing with its budget before this limit was imposed.

The bill was introduced by a group of House members in March 2023 and was referred to the Foreign Affairs Committee, where it would need to be approved before moving forward.

To provide for a limitation on availability of funds for the Western Hemisphere Drug Policy Commission, Salaries and Expenses for fiscal year 2024.

Biggs, Andy

 <p>This bill limits FY2024 funding for the Western Hemisphere Drug Policy Commission, Salaries and Expenses account.</p>